SHORT MINI FUTURE WARRANT - MEDTRONIC Stock

Certificat

DE000GG4SM74

Real-time BOERSE MUENCHEN 04:26:25 2024-07-12 am EDT
1.28 EUR 0.00% Intraday chart for SHORT MINI FUTURE WARRANT - MEDTRONIC
Current month+6.67%
1 month+36.17%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 1.28 0.00%
24-07-11 1.28 -9.22%
24-07-10 1.41 -0.70%
24-07-09 1.42 +2.90%
24-07-08 1.38 +5.34%

Real-time BOERSE MUENCHEN

Last update July 12, 2024 at 04:26 am EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying MEDTRONIC PLC
Issuer Goldman Sachs
WKN GG4SM7
ISINDE000GG4SM74
Date issued 2024-03-05
Strike 91.81 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.71
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.44
Lowest since issue 0.447
Spread 0.02
Spread %1.56%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.07 USD
Average target price
93.63 USD
Spread / Average Target
+19.93%
Consensus